Vinorelbine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00361 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Ewing sarcoma | KG + DL |
| 2 | fibromatosis, gingival | KG + DL |
| 3 | fibroma of lung | KG + DL |
| 4 | pulmonary sulcus neoplasm | KG + DL |
| 5 | lung germ cell tumor | KG + DL |
| 6 | hamartoma of lung | KG + DL |
| 7 | small cell lung carcinoma | KG + DL |
| 8 | lung benign neoplasm | KG + DL |
| 9 | lung hilum carcinoma | KG + DL |
| 10 | pulmonary blastoma | KG + DL |
| 11 | well-differentiated fetal adenocarcinoma of the lung | KG + DL |
| 12 | primary pulmonary lymphoma | KG + DL |
| 13 | Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome | KG + DL |
| 14 | inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia | KG + DL |
| 15 | junctional epidermolysis bullosa | KG + DL |
| 16 | ovarioleukodystrophy | KG + DL |
| 17 | junctional epidermolysis bullosa, non-Herlitz type | KG + DL |
| 18 | dehydratase deficiency | KG + DL |
| 19 | orbit sarcoma | KG + DL |
| 20 | synovial chondromatosis | KG + DL |
| 21 | giant cell tumor of soft tissue | KG + DL |
| 22 | sarcoma, avian | KG + DL |
| 23 | uterine corpus sarcoma | KG + DL |
| 24 | bone sarcoma | KG + DL |
| 25 | pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma | KG + DL |
| 26 | chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation | KG + DL |
| 27 | extraskeletal Ewing sarcoma/peripheral primitive neuroectodermal tumor | KG + DL |
| 28 | acute lymphoblastic/lymphocytic leukemia | KG + DL |
| 29 | vertebral anomalies and variable endocrine and T-cell dysfunction | KG + DL |
| 30 | Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone | KG + DL |
| 31 | ganglioneuroblastoma (disease) | KG + DL |
| 32 | 2q33.1 microdeletion syndrome | KG + DL |
| 33 | retroperitoneal neoplasm | KG + DL |
| 34 | neuroblastoma | KG + DL |
| 35 | chronic myelogenous leukemia, BCR-ABL1 positive | KG + DL |
| 36 | lung adenocarcinoma | KG + DL |
| 37 | sarcoma of cervix uteri | KG + DL |
| 38 | lung mixed small cell and squamous cell carcinoma | KG + DL |
| 39 | Hodgkins lymphoma | KG + DL |
| 40 | botryoid-type embryonal rhabdomyosarcoma of the vagina | KG + DL |
| 41 | rhabdomyosarcoma (disease) | KG + DL |
| 42 | adenosarcoma | KG + DL |
| 43 | embryonal extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 44 | parameningeal embryonal rhabdomyosarcoma | KG + DL |
| 45 | Wilms tumor | KG + DL |
| 46 | prostate embryonal rhabdomyosarcoma | KG + DL |
| 47 | extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 48 | liver sarcoma | KG + DL |
| 49 | Burkitt lymphoma | KG + DL |
| 50 | uterine ligament adenosarcoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.